Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening

Abstract

In high-risk families, women who test negative for the familial BRCA1/BRCA2 mutation have an increased risk of breast cancer consistent with genetic modifiers. In light of this, such women should still be considered for continued surveillance.